GlassScriptPhysician profile
Samuel B Low
NPI 1013973932
$160,142.44
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $11K · 2021: $720 · 2022: $26K · 2023: $69K · 2024: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $49K · Acquisitions: $21K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Consulting Fee: $1,500 · Food and Beverage: $26.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $48,500.00 |
| Acquisitions | $20,800.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,200.00 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $26.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $61,719.99 | 2020-2024 | (9210) Undivided |
| Biolase, INC. | $49,328.11 | 2019-2023 | Waterlase Iplus |
| Hu-Friedy Mfg. Co., LLC | $47,511.00 | 2019-2020 | |
| Epien Medical, INC. | $1,500.00 | 2024 | |
| Biohorizons Implant Systems INC. | $83.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.